Literature DB >> 30932448

Abnormal Uterine Bleeding in Premenopausal Women.

Noah Wouk1, Margaret Helton2.   

Abstract

Abnormal uterine bleeding is a common symptom in women. The acronym PALM-COEIN facilitates classification, with PALM referring to structural etiologies (polyp, adenomyosis, leiomyoma, malignancy and hyperplasia), and COEIN referring to nonstructural etiologies (coagulopathy, ovulatory dysfunction, endometrial, iatrogenic, not otherwise classified). Evaluation involves a detailed history and pelvic examination, as well as laboratory testing that includes a pregnancy test and complete blood count. Endometrial sampling should be performed in patients 45 years and older, and in younger patients with a significant history of unopposed estrogen exposure. Transvaginal ultrasonography is the preferred imaging modality and is indicated if a structural etiology is suspected or if symptoms persist despite appropriate initial treatment. Medical and surgical treatment options are available. Emergency interventions for severe bleeding that causes hemodynamic instability include uterine tamponade, intravenous estrogen, dilation and curettage, and uterine artery embolization. To avoid surgical risks and preserve fertility, medical management is the preferred initial approach for hemodynamically stable patients. Patients with severe bleeding can be treated initially with oral estrogen, high-dose estrogen-progestin oral contraceptives, oral progestins, or intravenous tranexamic acid. The most effective long-term medical treatment for heavy menstrual bleeding is the levonorgestrel-releasing intrauterine system. Other long-term medical treatment options include estrogen-progestin oral contraceptives, oral progestins, oral tranexamic acid, nonsteroidal anti-inflammatory drugs, and depot medroxyprogesterone. Hysterectomy is the definitive treatment. A lower-risk surgical option is endometrial ablation, which performs as well as the levonorgestrel-releasing intrauterine system. Select patients with chronic uterine bleeding can be treated with myomectomy, polypectomy, or uterine artery embolization.

Entities:  

Year:  2019        PMID: 30932448

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  6 in total

1.  Medroxyprogesterone Acetate for Abnormal Uterine Bleeding Due to Ovulatory Dysfunction: The Effect of 2 Different-Duration Regimens.

Authors:  Rukiye Ada Bender
Journal:  Med Sci Monit       Date:  2022-06-24

2.  Diagnostic Value of Vaginal Ultrasound under Improved Clustering Algorithm Combined with Hysteroscopy in Abnormal Uterine Bleeding.

Authors:  Yuhui Wang; Qionghui Long
Journal:  Comput Intell Neurosci       Date:  2022-05-27

Review 3.  Vibrational Biospectroscopy: An Alternative Approach to Endometrial Cancer Diagnosis and Screening.

Authors:  Roberta Schiemer; David Furniss; Sendy Phang; Angela B Seddon; William Atiomo; Ketankumar B Gajjar
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

4.  Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination.

Authors:  Katharine M N Lee; Eleanor J Junkins; Chongliang Luo; Urooba A Fatima; Maria L Cox; Kathryn B H Clancy
Journal:  Sci Adv       Date:  2022-07-15       Impact factor: 14.957

5.  Hemoglobin Levels and Platelet Counts after Hysteroscopy Due to Abnormal Uterine Bleeding.

Authors:  Katarzyna Jobda; Łukasz Szeszko; Grzegorz Wróbel; Marta Głuchowska; Joanna Krupińska; Artur Szeszko; Beata Makaruk; Przemysław Oszukowski; Paweł Zieliński
Journal:  Diagnostics (Basel)       Date:  2022-02-25

6.  Factors Influencing on Pain in Patients Undergoing Pipelle Endometrial Biopsy for Abnormal Uterine Bleeding: Why a Personalized Approach Should Be Applied?

Authors:  Milan Terzic; Gulzhanat Aimagambetova; Talshyn Ukybassova; Gauri Bapayeva; Aiym Kaiyrlykyzy; Faye Foster; Faina Linkov
Journal:  J Pers Med       Date:  2022-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.